- Home
- XERS vs PICS Comparison
XERS vs PICS Comparison
Compare XERS & PICS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | PICS |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | XERS | PICS |
|---|---|---|
| Price | $8.21 | $12.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $10.83 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 2.0M | 234.0K |
| Earning Date | 05-07-2026 | 05-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $34.37 | $33.65 |
| Revenue Next Year | $22.86 | $39.85 |
| P/E Ratio | $832.00 | ★ $29.44 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $4.87 | $8.32 |
| 52 Week High | $10.08 | $18.49 |
Technical Indicators
Market Signals| Indicator | XERS | PICS |
|---|---|---|
| Relative Strength Index (RSI) | 57.84 | 60.95 |
| Support Level | $8.00 | $11.16 |
| Resistance Level | $8.42 | $12.33 |
| Average True Range (ATR) | 0.34 | 0.57 |
| MACD | -0.09 | 0.06 |
| Stochastic Oscillator | 39.00 | 85.87 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About PICS PicS N.V. Class A Common Shares
PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.